LinkOPH

WAIKOLOA, Hawaii — Researchers are making strides in stem cell therapy in the treatment of glaucoma, but many questions remain unanswered, a speaker told colleagues here.“We’re very excited about progress being made in our lab and in others,” Jeffrey L. Goldberg, MD, PhD, said at Hawaiian Eye 2016. “Retinal ganglion cell differentiation, we’re starting to learn the molecular features of that. Transplantation, we have to focus on how to make a good retinal ganglion cell integrate properly. And there are a lot of additional questions that are getting us to move toward human therapy.”

Read more →

WAIKOLOA, Hawaii — At Hawaiian Eye, Alice T. Epitropoulos, MD, gives an overview of the many new – and old but still efficacious – treatments for lid margin and dry eye disease.

Read more →

WAIKOLOA, Hawaii — At Hawaiian Eye, John T. Corboy, MD, discusses the continuing outreach work and mission of the Hawaiian Eye Foundation in the Asia-Pacific region and beyond.

Read more →

WAIKOLOA, Hawaii — At Hawaiian Eye/Retina 2016, Donna M. McCune, CCS-P, COE, CPMA, discusses steps administrators can take with EHR with regard to the most challenging aspects of efficiency, accuracy and compliance.

Read more →

WAIKOLOA, Hawaii — At Hawaiian Eye, Mark Packer, MD, discusses the results of a post-FDA approval study of the Trulign accommodating toric IOL (Bausch + Lomb). He noted the results were similar to the FDA trial results, even with less stringent surgical parameters.

Read more →